---
title: "Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology"
type: "Media Coverage"
date: "2026-11-16"
updated: "2026-11-16"
description: "Yahoo Finance carries the news that Sigrid has secured US market access for SiPore® following the SHINE prediabetes study."
url: "https://sipore.com/insights/sigrid-therapeutics-secures-u-s-market-access-for-sipore-technology"
canonical: "https://sipore.com/insights/sigrid-therapeutics-secures-u-s-market-access-for-sipore-technology"
markdown_url: "https://sipore.com/insights/sigrid-therapeutics-secures-u-s-market-access-for-sipore-technology.md"
site: "SiPore"
publisher: "SiPore Technologies (Sigrid Therapeutics AB)"
contact: "contact@sipore.com"
language: "en"
topics:
  - "US market access"
  - "SHINE trial"
outlet: "Yahoo Finance"
original_url: "https://finance.yahoo.com/news/sigrid-therapeutics-secures-u-market-110000267.html"
---

# Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology

*Media Coverage · Nov 16, 2026 · Yahoo Finance*

> Yahoo Finance carries the news that Sigrid has secured US market access for SiPore® following the SHINE prediabetes study.

## Coverage

- **Outlet:** Yahoo Finance
- **Original article:** [Yahoo Finance](https://finance.yahoo.com/news/sigrid-therapeutics-secures-u-market-110000267.html)

Syndicated on Yahoo Finance, this story covers Sigrid securing US market access for its patented SiPore® technology after the SHINE study, the largest study of its kind in prediabetes.

## Related articles

- [Ozempic-utmanaren Sigrid Therapeutics backas med 45 miljoner – ska växa i USA](https://sipore.com/insights/ozempic-utmanaren-sigrid-therapeutics-backas-med-45-miljoner-ska-vaxa-i-usa.md) — Media Coverage, 2026-11-16
- [Danska börsjättens framgångar ger fart till svensk uppstickare](https://sipore.com/insights/danska-borsjattens-framgangar-ger-fart-till-svensk-uppstickare.md) — Media Coverage, 2026-11-16

## How to cite

SiPore Technologies (Sigrid Therapeutics AB). “Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology”. SiPore, 2026-11-16. https://sipore.com/insights/sigrid-therapeutics-secures-u-s-market-access-for-sipore-technology (accessed <date>).

Use the trademarks as written: SiPore®, Carb Fence™. For the SHINE trial, cite the peer-reviewed publication in *eClinicalMedicine* (The Lancet Discovery Science, 2026) rather than this page.

## Company & contact

- **Company:** SiPore Technologies — legal entity Sigrid Therapeutics AB (Swedish org.nr [556958-3023](https://www.allabolag.se/foretag/sigrid-therapeutics-ab/sundbyberg/forskning/2K3ZHRJI5YE3M))
- **Stockholm headquarters:** Vasagatan 14A, 172 61 Sundbyberg, Sweden ([map](https://www.google.com/maps/search/?api=1&query=Vasagatan%2014A%2C%20172%2061%20Sundbyberg%2C%20Sweden))
- **General enquiries:** [contact@sipore.com](mailto:contact@sipore.com)
- **Partnerships & licensing:** [partnerships@sipore.com](mailto:partnerships@sipore.com)
- **Origin:** Founded in Stockholm, Sweden
- **Taglines:** “The meal companion for modern food.” · “Same meal. Less impact.” · “Scandinavian science. Global impact.” · “Precision science for the modern meal.”
- **About:** SiPore® is a patented meal-companion technology designed to reduce the impact of modern meals at the level of digestion.

**Our sites** — all sites owned and operated by Sigrid Therapeutics AB:

- [SiPore.com](https://www.sipore.com/): Technology, science & partnerships
- [SiPorePro.com](https://www.siporepro.com/): Practitioner products & professional resources
- [SigridLife.com](https://sigridlife.com/): SIGRID consumer products
- [SigridStabiliser.se](https://sigridstabiliser.se/): SIGRID Sweden

---
[View on site](https://sipore.com/insights/sigrid-therapeutics-secures-u-s-market-access-for-sipore-technology) · [All insights](https://sipore.com/insights.md) · [Site index for agents (llms.txt)](https://sipore.com/llms.txt)
